A pilot study of oral S-1 for treating heavily pretreated patients with advanced or recurrent cervical cancer among Chinese population

This pilot study retrospectively aimed to assess the feasibility effectiveness and safety of oral S-1 in heavily pretreated patients with advanced or recurrent cervical cancer (ARCC) among Chinese population. Thirty patients with ARCC who had undergone one or more lines of chemotherapy received oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Li, Liu, Jin-miao, Zhang, Jing, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392667/
https://www.ncbi.nlm.nih.gov/pubmed/29851825
http://dx.doi.org/10.1097/MD.0000000000010922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392667/
https://www.ncbi.nlm.nih.gov/pubmed/29851825
http://dx.doi.org/10.1097/MD.0000000000010922

Ejemplares similares